Skip to main content
ImmuneCited

Iron для Pediatric Immune Support

C Доказательства Доказательства ограничены небольшими исследованиями, однако имеются некоторые положительные сигналы.

Iron supplementation in deficient children may help restore lymphocyte and neutrophil function. However, excess iron may feed pathogens and worsen infections. Supplementation should be guided by documented deficiency status.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Dpediatric\u002Dimmune\u002Dsupport'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Итог

Iron supplementation in deficient children may help restore lymphocyte and neutrophil function. However, excess iron may feed pathogens and worsen infections. Supplementation should be guided by documented deficiency status.

Key Study Findings

Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Systematic Review and Meta-Analysis n=7014
Trace Elements and Risk of Immune-Mediated Skin Disease: A Systematic Review and Meta-analysis.
Dose: None или: Placebo Эффект: Standardized mean differences reported for each element and disease combination (specific values not None
In Vitro
Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia.
Dose: None или: Minoxidil Outcome: Hair regeneration in AGA mice Эффект: None None

Популяция: AGA mouse model

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None или: None Outcome: Micronutrient deficiency management in pediatric IBD Эффект: None None

Популяция: Children with inflammatory bowel disease (review)

Other
Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis.
Dose: None или: Uncoated EcN and UC model mice Outcome: UC inflammation and probiotic intestinal retention Эффект: None None

Популяция: Obese C57 mice with DSS-induced UC

Review
Frontal Fibrosing Alopecia in Men: A Review of the Literature.
Dose: None или: None Outcome: None Эффект: None None

Популяция: Review of frontal fibrosing alopecia in men

Key Statistics

5

Исследования

400

Участники

Positive

C

Оценка

Referenced Papers

Journal of clinical … 2025 1 цитирований
International journal of … 2024 3 цитирований
The Cochrane database … 2024 1 цитирований
Clinical reviews in … 2021 304 цитирований
Dermatitis : contact, … 2019 7 цитирований
World journal of … 2016 238 цитирований
Deutsches Arzteblatt international 2016 99 цитирований
Digestive diseases (Basel, … 2016 41 цитирований
The Cochrane database … 2015 147 цитирований
Der Internist 2015
Journal of immunological … 2014 13 цитирований
European journal of … 2012 225 цитирований
Inflammatory bowel diseases 2012 224 цитирований
Sleep medicine reviews 2012 139 цитирований
Food and nutrition … 2009 122 цитирований
Pharmacoepidemiology and drug … 2009 22 цитирований
The Annals of … 2008 82 цитирований
The Israel Medical … 2008 61 цитирований
American journal of … 2007 61 цитирований
Premenstrual syndrome. Systematic Review
BMJ clinical evidence 2007
Cardiovascular research 2006 42 цитирований
Heart failure reviews 2006 22 цитирований
Journal of pediatric … 2006 7 цитирований
The British journal … 2002 358 цитирований
American journal of … 1999 226 цитирований
Dermatologic clinics 1998 121 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
8-18 mg/day
deficiency:
Per medical guidance based on ferritin levels

Верхний предел: 45 mg/day (elemental iron)

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Mixed --
None -- Mixed 7014
None -- Positive --
None -- Neutral --
None -- Positive --
None -- Mixed --
Disease-modifying agents (tolvaptan, etc.) -- Positive --
None -- Positive --

Лучшее время приёма: On empty stomach with vitamin C for best absorption; avoid with calcium, coffee, or tea

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

Известные взаимодействия

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors and H2 blockers (reduce absorption)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

Допустимый верхний уровень потребления: 45 mg/day (elemental iron)

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Iron help with Pediatric Immune Support?
Based on 5 studies with 400 participants, there is limited but promising evidence that Iron may support Pediatric Immune Support management. Our evidence grade is C (Some Evidence).
How much Iron should I take for Pediatric Immune Support?
Studies have used various dosages. A commonly studied range is 8-18 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Iron?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Iron and Pediatric Immune Support?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Другие ингредиенты для Pediatric Immune Support

References

  1. [1] Zheng Xing et al.. Acta Biomater. 2025. Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia. doi:10.1016/j.actbio.2025.05.039 PubMed
  2. [2] Yozahandy A Abarca et al.. Cureus. 2025. Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities. doi:10.7759/cureus.78298 PubMed
  3. [3] Tiziana Galeazzi et al.. Nutrients. 2025. Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do? doi:10.3390/nu17091425 PubMed
  4. [4] Xie Chengfeng et al.. Colloids Surf B Biointerfaces. 2025. Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis. doi:10.1016/j.colsurfb.2025.115035 PubMed
  5. [5] Ana Melián-Olivera et al.. J Clin Med. 2025. Frontal Fibrosing Alopecia in Men: A Review of the Literature. doi:10.3390/jcm14061914 PubMed
  6. [6] Xinyi Shao et al.. Nutr Rev. 2025. Trace Elements and Risk of Immune-Mediated Skin Disease: A Systematic Review and Meta-analysis. doi:10.1093/nutrit/nuaf015 PubMed
  7. [7] Jiayang Zhang et al.. J Pineal Res. 2024. Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice. doi:10.1111/jpi.12964 PubMed
  8. [8] Xuefei Zhang et al.. Int J Nanomedicine. 2024. Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies. doi:10.2147/IJN.S477820 PubMed
  9. [9] Kitty St Pierre et al.. Cochrane Database Syst Rev. 2024. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. doi:10.1002/14651858.CD010294.pub3 PubMed
  10. [10] Sule Goksin. North Clin Istanb. 2022. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. doi:10.14744/nci.2022.78790 PubMed
  11. [11] Cheng Zhou et al.. Clin Rev Allergy Immunol. 2021. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. doi:10.1007/s12016-021-08883-0 PubMed
  12. [12] Eva Jover et al.. Biomedicines. 2021. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. doi:10.3390/biomedicines9060639 PubMed
  13. [13] Eva Hadadi et al.. Endocr Relat Cancer. 2021. Role of circadian rhythm disorders on EMT and tumour-immune interactions in endocrine-related cancers. doi:10.1530/ERC-20-0390 PubMed
  14. [14] Olla A Khalifa et al.. BMC Vet Res. 2021. The impact of vitamin E and/or selenium dietary supplementation on growth parameters and expression levels of the growth-related genes in … doi:10.1186/s12917-021-02963-1 PubMed
  15. [15] Dimitrios T Papadimitriou et al.. World J Clin Pediatr. 2021. Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review. doi:10.5409/wjcp.v10.i6.192 PubMed
  16. [16] Rasika Ranaweerage et al.. BMC Nephrol. 2021. Hypokalaemic paralysis and metabolic alkalosis in a patient with Sjögren syndrome: a case report and literature review. doi:10.1186/s12882-021-02371-5 PubMed
  17. [17] M N Chang et al.. J Dairy Sci. 2020. Effects of different types of zinc supplement on the growth, incidence of diarrhea, immune function, and rectal microbiota of newborn … doi:10.3168/jds.2019-17610 PubMed
  18. [18] Sandeep K Riar et al.. J Clin Sleep Med. 2019. Restless Legs Syndrome in Chronic Kidney Disease: Is Iron or Inflammatory Status To Blame? doi:10.5664/jcsm.8028 PubMed
  19. [19] Aleksi J Hendricks et al.. Dermatitis. 2019. Clinical Pearls on Sleep Management in Atopic Dermatitis. doi:10.1097/DER.0000000000000523 PubMed
  20. [20] Stergios A Polyzos et al.. Diabetes Obes Metab. 2017. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and … doi:10.1111/dom.12989 PubMed
  21. [21] Danuta Owczarek et al.. World J Gastroenterol. 2016. Diet and nutritional factors in inflammatory bowel diseases. doi:10.3748/wjg.v22.i3.895 PubMed
  22. [22] Hans Wolff et al.. Dtsch Arztebl Int. 2016. The Diagnosis and Treatment of Hair and Scalp Diseases. doi:10.3238/arztebl.2016.0377 PubMed
  23. [23] Wolfgang Kruis et al.. Dig Dis. 2016. Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not? doi:10.1159/000443012 PubMed
  24. [24] Gwang Seong Choi et al.. Ann Dermatol. 2016. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia. doi:10.5021/ad.2016.28.4.444 PubMed
  25. [25] Mariè van der Merwe et al.. J Sports Med (Hindawi Publ Corp). 2016. The Influence of Methylsulfonylmethane on Inflammation-Associated Cytokine Release before and following Strenuous Exercise. doi:10.1155/2016/7498359 PubMed
  26. [26] Zhe Qu et al.. Neuromolecular Med. 2016. Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration. doi:10.1007/s12017-016-8410-1 PubMed
  27. [27] Mahsa Salehi et al.. Cochrane Database Syst Rev. 2015. Interventions for central serous chorioretinopathy: a network meta-analysis. doi:10.1002/14651858.CD011841.pub2 PubMed
  28. [28] H Wolff. Internist (Berl). 2015. [Drug treatment of alopecia]. doi:10.1007/s00108-015-3763-3 PubMed
  29. [29] Robert E Click. J Immunol Methods. 2014. Review: 2-mercaptoethanol alteration of in vitro immune functions of species other than murine. doi:10.1016/j.jim.2013.11.007 PubMed
  30. [30] Priya Batra et al.. Int J Med Mushrooms. 2013. Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. doi:10.1615/intjmedmushr.v15.i2.20 PubMed
  31. [31] Nils Hovdenak et al.. Eur J Obstet Gynecol Reprod Biol. 2012. Influence of mineral and vitamin supplements on pregnancy outcome. doi:10.1016/j.ejogrb.2012.06.020 PubMed
  32. [32] Caroline Hwang et al.. Inflamm Bowel Dis. 2012. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. doi:10.1002/ibd.22906 PubMed
  33. [33] Leonard B Weinstock et al.. Sleep Med Rev. 2012. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. doi:10.1016/j.smrv.2011.09.003 PubMed
  34. [34] Sonja Y Hess et al.. Food Nutr Bull. 2009. Effects of maternal zinc supplementation on pregnancy and lactation outcomes. doi:10.1177/15648265090301S105 PubMed
  35. [35] Jen-Tzer Gau et al.. Pharmacoepidemiol Drug Saf. 2009. Uses of proton pump inhibitors and serum potassium levels. doi:10.1002/pds.1795 PubMed
  36. [36] Courtney I Jarvis et al.. Ann Pharmacother. 2008. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. doi:10.1345/aph.1K673 PubMed
  37. [37] Gisele Zandman-Goddard et al.. Isr Med Assoc J. 2008. Hyperferritinemia in autoimmunity. PubMed
  38. [38] Rajiv Agarwal. Am J Nephrol. 2007. Nonhematological benefits of iron. doi:10.1159/000107927 PubMed
  39. [39] Irene Kwan et al.. BMJ Clin Evid. 2007. Premenstrual syndrome. PubMed
  40. [40] Yao Sun et al.. Cardiovasc Res. 2006. Oxidative stress in aldosteronism. doi:10.1016/j.cardiores.2006.03.007 PubMed
  41. [41] Veronica Franco et al.. Clin Exp Pharmacol Physiol. 2006. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice. doi:10.1111/j.1440-1681.2006.04434.x PubMed
  42. [42] Sabine Strassburg et al.. Heart Fail Rev. 2006. Metabolic and immunologic derangements in cardiac cachexia: where to from here? doi:10.1007/s10741-006-9193-5 PubMed
  43. [43] Faith Claman et al.. J Pediatr Health Care. 2006. Premenstrual syndrome and premenstrual dysphoric disorder in adolescence. doi:10.1016/j.pedhc.2006.06.001 PubMed
  44. [44] Philip C Calder et al.. Br J Nutr. 2002. The immune system: a target for functional foods? doi:10.1079/BJN2002682 PubMed
  45. [45] T B Klepser et al.. Am J Health Syst Pharm. 1999. Unsafe and potentially safe herbal therapies. doi:10.1093/ajhp/56.2.125 PubMed
  46. [46] J Shapiro et al.. Dermatol Clin. 1998. Hair regrowth. Therapeutic agents. doi:10.1016/s0733-8635(05)70017-6 PubMed
  47. [47] J Tanaka et al.. Glia. 1997. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. PubMed

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.